Viemed Healthcare, Inc. (VMD) financial statements and ratios from SEC XBRL: revenue $0.3B (TTM), net margin 5.5%, revenue growth 20.5% YoY, P/E 30.1. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $270.28M |
| Revenue (TTM) | $0.3B |
| Net Margin | 5.5% |
| Operating Margin (TTM) | 7.3% |
| Net Debt / EBITDA | -0.1 |
| Revenue Growth (YoY) | 20.5% |
| EPS Growth (YoY) | 31.0% |
| FCF Growth (YoY) | 805.2% |
| P/E Ratio | 30.1 |
| EV / EBITDA | 9.9 |
| Price / Book | 2.39 |
| Price / Sales | 1.16 |
| FCF Yield | 3.9% |
| Altman Z-Score | 6.29 (safe) |
| Piotroski F-Score | 6/9 |
| Piotroski checks passed | 6 of 9 |
| Industry P/E (Healthcare Services) | 25.4 |
| Sector P/E (Healthcare) | 21.9 |
VMD overview · VMD earnings · VMD KPIs · VMD documents · VMD ownership · VMD peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.